Recordati S.A. Chemical and Pharmaceutical Company
45Patents
0Active
45Granted
35Portfolio score
Filing activity: Oct 10, 1972 → Oct 1, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5674533A | Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension | Human Necessities | 632 | Expired |
| US5472704A | Pharmaceutical controlled-release composition with bioadhesive properties | Human Necessities | 157 | Expired |
| US5571533A | Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide | Human Necessities | 85 | Expired |
| US5460828A | Process for the preparation of microgranules suitable for suspension in fluids | Human Necessities | 53 | Expired |
| US5527545A | Liquid-suspension controlled-release pharmaceutical composition | Human Necessities | 45 | Expired |
| US5474994A | Bicyclic heterocyclic derivatives having .alpha..sub.1 -adrenergic and 5HT.sub.1A | Chemistry; Metallurgy | 39 | Expired |
| US5605896A | Bicyclic heterocyclic derivatives having .alpha..sub.1 adrenergic and 5HT.sub.1A activities | Chemistry; Metallurgy | 39 | Expired |
| US5296236A | Controlled release therapeutic system for a liquid pharmaceutical formulations | Human Necessities | 36 | Expired |
| US5952021A | Stabilized biologically active compounds contained in coated microgranules which can be suspended in alimentary fluids | Emerging Cross-Sectional Technologies | 32 | Expired |
| US5403842A | Benzopyran and benzothiopyran derivatives | Chemistry; Metallurgy | 30 | Expired |
| US6333044A | Therapeutic compositions for intranasal administration which include KETOROLAC.RTM. | Human Necessities | 27 | Expired |
| US4705797A | N-(3,3-diphenylpropyl) aminoethyl esters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid, compositions and use | Chemistry; Metallurgy | 17 | Expired |
| US6303606A | Use of selective antagonists of the .alpha.1B-adrenergic receptor for improvement of sexual dysfunction | Physics | 16 | Expired |
| US4675319A | Antianaphylactic and antibronchospastic piperazinyl-(N-substituted phenyl)carboxamides, compositions and use | Chemistry; Metallurgy | 16 | Expired |
| US5670171A | Liquid-suspension controlled-release pharmaceutical composition | Human Necessities | 15 | Expired |
| US5510119A | Controlled release therapeutic system for liquid pharmaceutical formulations | Human Necessities | 14 | Expired |
| US6071920A | 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring | Chemistry; Metallurgy | 10 | Expired |
| US5990114A | Use of 5-HT.sub.1A receptor antagonists for the treatment of urinary incontinence | Human Necessities | 7 | Expired |
| US6440963B1 | Use of selective COX-2 inhibitors for the treatment of urinary incontinence | Physics | 7 | Expired |
| US5165937A | Controlled release tablets containing flavoxate | Human Necessities | 6 | Expired |
| US6399614B1 | 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring | Chemistry; Metallurgy | 6 | Expired |
| US5405619A | Controlled release therapeutic system for liquid pharmaceutical formulations | Human Necessities | 6 | Expired |
| US4940711A | Antihypertensive N-piperazinylalkanoylanilides | Chemistry; Metallurgy | 5 | Expired |
| US4806534A | Therapeutically active flavonyl-1,4-dihydrophyridines | Chemistry; Metallurgy | 4 | Expired |
| US5756737A | Process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine | Chemistry; Metallurgy | 4 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.